Join the Galcanezumab group to help and get support from people like you.
Galcanezumab News
FDA Approves Emgality (galcanezumab-gnlm) for the Treatment of Episodic Cluster Headache
INDIANAPOLIS, June 04, 2019 – Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality (galcanezumab-gnlm) injection (300 mg) for the t...
FDA Approves Emgality (galcanezumab-gnlm) for the Preventive Treatment of Migraine in Adults
INDIANAPOLIS, Sept. 27, 2018 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality™ (galcanezumab-gnlm) 120 mg i...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Cluster Headaches, Migraine Prevention, Migraine Prophylaxis, Chronic Migraine, Headache, Migraine